期刊的影响因子--文章列表

期刊文章列表
Keliang Chen¹，Tao Wang²，Yong Li¹，Jun Wu¹，Cheng-Xiao Zhao¹，Sheng Liu¹，Fengrun Sun²，Yehong Fang²，Jiahuan Hu¹，Jinping Hu¹，Chong-Jing Zhang¹，Haibo Yu¹，Chao Ma²，Shi-Shan Yu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Institute of Basic Medical Sciences，Neuroscience Center，Chinese Academy of Medical Sciences，Department of Human Anatomy，Histology and Embryology，School of Basic Medicine，Peking Union Medical College）.Rhodojaponin Ⅵ indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain[J].Acta Pharmaceutica Sinica B,2023,第3期 Shiyang Shen，Teng Li，Jinyi Fan，Quanlin Shao，He Dong，Xiao Xu，Ran Mo（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，Center of Advanced Pharmaceuticals and Biomaterials，School of Life Science and Technology，China Pharmaceutical University）.Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor[J].Acta Pharmaceutica Sinica B,2023,第3期 Juanjuan Feng^1,2，Zhengke Lian¹，Xinting Xia¹，Yue Lu¹，Kewen Hu³，Yunpeng Zhang¹，Yanan Liu¹，Longmiao Hu¹，Kun Yuan¹，Zhenliang Sun²，Xiufeng Pang¹（Shanghai Key Laboratory of Regulatory Biology，School of Life Sciences，East China Normal University；Joint Center for Translational Medicine，Southern Medical University Affiliated Fengxian Hospital；Cancer Institute，Fudan University Shanghai Cancer Center，Department of Oncology，Shanghai Medical College，Fudan University）.Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer[J].Acta Pharmaceutica Sinica B,2023,第3期 Xin Jin^1,2,3，Shuai Wang^1,2，Limin Zhao^1,2,3，Wenjuan Huang^1,2，Yinxiang Zhang^1,2，Christophe Pannecouque⁴，Erik De Clercq⁴，Ge Meng^1,2，Huri Piao³，Fener Chen^1,2,3（Engineering Center of Catalysis and Synthesis for Chiral Molecules，Department of Chemistry，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules，Ministry of Education，College of Pharmacy，Yanbian University；Rega Institute for Medical Research，KU Leuven）.Development of fluorine-substituted NH₂-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors：Boosting the safety and metabolic stability[J].Acta Pharmaceutica Sinica B,2023,第3期 Ling-Ling Wu^1,2,3，Qinxin Zhao^1,2,3，Qinghua Wang¹，Qingyang Zhang¹，Feiya Yang^2,3，Bo Zheng⁴，Hai-Yu Hu¹，Nianzeng Xing^2,3,5（State Key Laboratory of Bioactive Substances and Function of Natural Medicine，Institute of Materia Medica，Peking Union Medical College and Chinese Academy of Medical Sciences；Department of Urology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Pathology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Urology，Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital，Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University）.Membrane dual-targeting probes：A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection[J].Acta Pharmaceutica Sinica B,2023,第3期 Jiang Wu¹，Wenfeng Gou²，Zhiyun Wang³，Huajie Chang³，Deguan Li²，Wenbin Hou²，Changxiao Liu⁴（Department of Pharmaceutical Engineering，School of Chemical Engineering and Technology，Tianjin University；Institute of Radiation Medicine，Chinese Academy of Medical Sciences；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；Research Center for New Drug Evaluation，the State Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Discovery of the radio-protecting effect of Ecliptae Herba,its constituents and targeting p53-mediated apoptosis in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第3期 Tengjie Yu¹，Zhihao Zhou¹，Shijia Liu²，Changjian Li¹，Zhi-Wei Zhang³，Yong Zhang³，Wei Jin¹，Keanqi Liu¹，Shuying Mao¹，Lei Zhu²，Lin Xie¹，Guangji Wang¹，Yan Liang¹（Key Lab of Drug Metabolism & Pharmacokinetics，State Key Laboratory of Natural Medicines，China Pharmaceutical University；Affliated Hospital of Nanjing University of Chinese Medicine；College of Chemical & Pharmaceutical Engineering，Hebei University of Science & Technology）.The role of phosphatidylcholine 34：1 in the occurrence,development and treatment of ulcerative colitis[J].Acta Pharmaceutica Sinica B,2023,第3期 Xueqin Huang，Bingbing Sheng，Hemi Tian，Qiuxia Chen，Yingqi Yang，Brian Bui²，Jiang Pi³，Huaihong Cai³，Shanze Chen，Jianglin Zhang，Wei Chen²，Haibo Zhou，Pinghua Sun（The Second Clinical Medical College (Shenzhen People’s Hospital)，College of Pharmacy，Jinan University；Department of Physics，the University of Texas at Arlington；Department of Chemistry，Jinan University）.Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Qunjie Bi¹，Xu Song²，Yangyang Zhao¹，Xueyi Hu¹，Huan Yang¹，Rongrong Jin¹，Yu Nie¹（National Engineering Research Center for Biomaterials，College of Biomedical Engineering，Sichuan University；NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial & Institute of Regulatory Science for Medical Devices & NMPA Research Base of Regulatory Science for Medical Devices，Sichuan University）.Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhuo Feng¹，Yuchen Wang¹，Haiheng Xu¹，Yunfei Guo¹，Wen Xia¹，Chenxuan Zhao¹，Xiaozhi Zhao²，Jinhui Wu^1,3（State Key Laboratory of Pharmaceutical Biotechnology，Chemistry and Biomedicine Innovation Center，Medical School of Nanjing University；Department of Andrology，Drum Tower Hospital，Medical School of Nanjing University；Jiangsu Key Laboratory for Nano Technology，Nanjing University）.Recent advances in bacterial therapeutics based on sense and response[J].Acta Pharmaceutica Sinica B,2023,第3期 Lu Zhang¹，Xiaolei Zhou²，Bowen Liu³，Xuhe Shi¹，Xianmeng Li¹，Feifei Xu¹，Xueli Fu¹，Xue Wang¹，Kai Ye¹，Tianzhi Jin¹，Huimin Sun¹，Qianqian Li¹，Weiying Zhang¹，Lihong Ye¹（State Key Laboratory of Medicinal Chemical Biology，Tianjin Key Laboratory of Protein Sciences，Department of Biochemistry and Molecular Biology，College of Life Sciences，Nankai University；College of Food Science & Biology，Hebei University of Science and Technology；Henan Key Laboratory of Immunology and Targeted Drugs，School of Laboratory Medicine，Xinxiang Medical University）.HBXIP blocks myosin-ⅡA assembly by phosphorylating and interacting with NMHC-ⅡA in breast cancer metastasis[J].Acta Pharmaceutica Sinica B,2023,第3期 Minxuan Xu^1,2,3，Jun Tan^1,2，Liancai Zhu³，Chenxu Ge^1,2,3，Wei Dong⁴，Xianling Dai^1,3，Qin Kuang^1,3，Shaoyu Zhong^1,2，Lili Lai^1,2，Chao Yi^1,2，Qiang Li^1,2，Deshuai Lou^1,2，Linfeng Hu^1,2,3，Xi Liu^1,2，Gang Kuang^1,2，Jing Luo^1,2，Jing Feng³，Bochu Wang³（Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region，School of Biological and Chemical Engineering，Chongqing University of Education；College of Modern Health Industry，Chongqing University of Education；Key Laboratory of Biorheological Science and Technology (Chongqing University)，Ministry of Education，College of Bioengineering，Chongqing University；Shandong Cancer Hospital and Institute，Shandong First Medical University & Shandong Academy of Medical Sciences）.The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Sae-Bom Yoon^1,2，Hyowon Hong¹，Hee-Jong Lim¹，Ji Hye Choi¹，Yoon Pyo Choi³，Seong Wook Seo³，Hyuk Woo Lee³，Chong Hak Chae¹，Woo-Kyu Park¹，Hyun Young Kim¹，Daeyoung Jeong¹，Tran Quang De¹，Chang-Seon Myung²，Heeyeong Cho¹（Therapeutics & Biotechnology Division，Korea Research Institute of Chemical Technology；Department of Pharmacology，Chungnam National University College of Pharmacy；Future Medicine Co.Ltd.Rm616 LH-Business Growth Center）.A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengyao Hao¹，Rong Fu¹，Jun Tai，Zhenhuan Tian³，Xia Yuan⁴，Yang Chen⁵，Mingjin Wang¹，Huimin Jiang¹，Ming Ji¹，Fangfang Lai¹，Nina Xue¹，Liping Bai⁶，Yizhun Zhu⁶，Xiaoxi Lv¹，Xiaoguang Chen¹，Jing Jin¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences，Peking Union Medical College；Department of Otolaryngology，Head and Neck Surgery，Children’s Hospital Capital Institute of Pediatrics；Department of Thoracic Surgery，Peking Union Medical College Hospital，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，School of Pharmaceutical，Guangzhou University of Chinese Medicine；State Key Laboratory of Quality Research in Chinese Medicine，Macau Institute for Applied Research in Medicine and Health，Macau University of Science and Technology）.S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung[J].Acta Pharmaceutica Sinica B,2023,第3期 Xiaoli Wei¹，Fan Yin^2,3，Miaomiao Wu^1,3，Qianqian Xie^3,4，Xueqin Zhao^3,4，Cheng Zhu¹，Ruiqian Xie^3,4，Chongqing Chen^3,4，Menghua Liu^3,4，Xueying Wang¹，Ruixue Ren¹，Guijie Kang^3,4，Chenwen Zhu¹，Jingjing Cong^3,4，Hua Wang^1,4，Xuefu Wang^3,4（Department of Oncology，the First Affiliated Hospital of Anhui Medical University；Department of Pharmacy，Huainan First People's Hospital，the First Affiliated Hospital of Anhui University of Science and Technology；School of Pharmacy，Anhui Medical University；Inflammation and Immune Mediated Diseases Laboratory of Anhui Province，Anhui Medical University）.G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes[J].Acta Pharmaceutica Sinica B,2023,第3期 Ning Shao¹，Xueyang Ma²，Ying-Ying Zhang¹，Donghui Yang²，Ming Ma²，Gong-Li Tang^1,3（State Key Laboratory of Bioorganic and Natural Products Chemistry，Center for Excellence in Molecular Synthesis，Shanghai Institute of Organic Chemistry，University of Chinese Academy of Sciences，Chinese Academy of Sciences；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；School of Chemistry and Materials Science Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis[J].Acta Pharmaceutica Sinica B,2023,第3期 Geni Ye，Maohua Huang，Yong Li，Jie Ouyang，Minfeng Chen，Qing Weng，Xiaobo Li，Huhu Zeng，Pei Long，Zepei Fan，Junqiang Yin，Wencai Ye，Dongmei Zhang（College of Pharmacy；Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research；Integrated Chinese and Western Medicine Postdoctoral Research Station；Department of Musculoskeletal Oncology）.Author correction to“The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway”[Acta Pharm Sin B 12(2022)1288–1304][J].药学学报(英文版),2023,第3期 Huaqing Zheng，Xiaolong Li，Xin Zeng，Chengcui Huang，Mingming Ma，Xiaofei Lv，Yajuan Zhang，Lu Sun，Guanlei Wang，Yanhua Du，Yongyuan Guan（Department of Pharmacology）.Author correction to“TMEM16A inhibits angiotensin Ⅱ-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”[Acta Pharm Sin B 11(12)(2021)3994–4007][J].药学学报(英文版),2023,第3期（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2023,第3期 Haowen Xu^1,2，Jiahao Chen¹，Pan Chen¹，Weifeng Li¹，Jingjing Shao^1,2，Shanshan Hong¹，Yi Wang¹，Lingfeng Chen²，Wu Luo^1,3，Guang Liang^1,2（Chemical Biology Research Center，School of Pharmaceutical Sciences，Wenzhou Medical University；School of Pharmaceutical Sciences，Hangzhou Medical College；Medical Research Center，the First Affiliated Hospital of Wenzhou Medical University）.Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases[J].Acta Pharmaceutica Sinica B,2023,第2期 Ze Mi¹，Qing Yao^1,2,3，Yan Qi²，Jinhai Zheng⁴，Jiahao Liu¹，Zhenguo Liu¹，Hongpei Tan¹，Xiaoqian Ma¹，Wenhu Zhou^1,5,6，Pengfei Rong^1,6（Department of Radiology，The Third Xiangya Hospital，Central South University；Department of Pathology，Shihezi University School of Medicine and the First Affiliated Hospital to Shihezi University School of Medicine；Department of Pathology，Cangzhou Central Hospital&the Affiliated to Hebei Medical University；School of Biomedical Sciences，Hunan University；Xiangya School of Pharmaceutical Sciences，Central South University；Key Laboratory of Biological Nanotechnology of National Health Commission）.Salmonella-mediated blood-brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy[J].Acta Pharmaceutica Sinica B,2023,第2期 Huaan Li^1,2，Fei Peng³，Xiaohui Yan⁴，Chun Mao⁵，Xing Ma⁶，Daniela A.Wilson⁷，Qiang He⁸，Yingfeng Tu^1,2（Department of Pharmacy，Zhujiang Hospital，Southern Medical University；School of Pharmaceutical Science，Guangdong Provincial Key Laboratory of New Drug Screening，Southern Medical University；School of Materials Science and Engineering，Sun Yat-Sen University；State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics&Centre for Molecular Imaging and Translational Medicine，School of Public Health，Xiamen University；National and Local Joint Engineering Research Center of Biomedical Functional Materials，School of Chemistry and Materials Science，Nanjing Normal University；Sauvage Laboratory for Smart Materials，School of Materials Science and Engineering，Harbin Institute of Technology(Shenzhen)；Institute for Molecules and Materials，Radboud University；Key Laboratory of Microsystems and Microstructures Manufacturing(Ministry of Education)，School of Medicine and Health，Harbin Institute of Technology）.Medical micro-and nanomotors in the body[J].Acta Pharmaceutica Sinica B,2023,第2期 Yujun Zhou¹，Jingshu Tang¹，Jiaqi Lan¹，Yong Zhang¹，Hongyue Wang¹，Qiuyu Chen¹，Yuying Kang¹，Yang Sun²，Xinhong Feng³，Lei Wu¹，Hongtao Jin^4,5，Shizhong Chen²，Ying Peng¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences&Peking Union Medical College；Department of Natural Medicines，School of Pharmaceutical Sciences，Peking University；Department of Neurology，Beijing Tsinghua Changgung Hospital，School of Clinical Medicine，Tsinghua University；New Drug Safety Evaluation Center，Institute of Materia Medica，Chinese Academy of Medical Sciences&Peking Union Medical College；NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug）.Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis[J].Acta Pharmaceutica Sinica B,2023,第2期 Yeuan Ting Lee，Yi Jer Tan，Chern Ein Oon（Institute for Research in Molecular Medicine （INFORMM），Universiti Sains Malaysia）.Benzimidazole and its derivatives as cancer therapeutics：The potential role from traditional to precision medicine[J].Acta Pharmaceutica Sinica B,2023,第2期 Chen Fu^1,2，Lifeng Yu¹，Yuxi Miao^1,2,3，Xinli Liu⁴，Zhaojin Yu^1,2，Minjie Wei^1,2,3（Department of Pharmacology，School of Pharmacy，China Medical University；Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation，China Medical University；Liaoning Medical Diagnosis and Treatment Center；Department of Digestive Oncology，Cancer Hospital of China Medical University，Liaoning Cancer Hospital&Institute）.Peptide-drug conjugates（PDCs）：a novel trend of research and development on targeted therapy, hype or hope?[J].Acta Pharmaceutica Sinica B,2023,第2期 Jizhou Tan^1,2，Ting Liu^3,4，Wenzhe Fan¹，Jialiang Wei¹，Bowen Zhu¹，Yafang Liu²，Lingwei Liu¹，Xiaokai Zhang¹，Songling Chen²，Haibiao Lin^3,4，Yuanqing Zhang⁵，Jiaping Li¹（Department of Interventional Oncology，the First Affiliated Hospital，Sun Yat-sen University；Department of Stomatology，the First Affiliated Hospital，Sun Yat-sen University；Department of Laboratory Medicine，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine，Guangdong Provincial Hospital of Traditional，Chinese Medicine；Second Clinical Medical College，Guangzhou University of Chinese Medicine；School of Pharmaceutical Sciences，Sun Yat-sen University）.Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1^highCD11b⁺cells elimination in hepatocellular carcinoma[J].Acta Pharmaceutica Sinica B,2023,第2期 Zhengjie Lu^1,2，Yu Guo^1,3，Dan Xu^1,3，Hao Xiao^2,3，Yongguo Dai¹，Kexin Liu¹，Liaobin Chen^2,3，Hui Wang^1,3（Department of Pharmacology，Wuhan University School of Basic Medical Science；Department of Orthopedic Surgery，Zhongnan Hospital of Wuhan University；Hubei Provincial Key Laboratory of Developmentally Originated Disorder）.Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy[J].Acta Pharmaceutica Sinica B,2023,第2期 Lujing Geng¹，Tong Lu²，Huaqing Jing¹，Yue Zhou¹，Xiaoyang Liang¹，Jiao Li²，Nan Li¹（Tianjin Key Laboratory of Drug Delivery&High-Efficiency，School of Pharmaceutical Science and Technology，Tianjin University；School of Precision Instruments and Optoelectronics Engineering，Tianjin University）.Iron-based and BRD₄-downregulated strategy for amplified ferroptosis based on pH-sensitive/NIR-Ⅱ-boosted nano-matchbox[J].Acta Pharmaceutica Sinica B,2023,第2期 Jianjun Cheng^1,2,3，Haitian Zhao^1,4,5，Bin Li⁶，Hua Zhang²，Qianyu Zhao^1,2，Shiyao Fu^1,2，Ying Han^1,2，Weihong Lu^1,4,5，Jiahua Shi³，Xin Yang^1,2,4,5（School of Medicine and Health，Harbin Institute of Technology；School of Chemistry and Chemical Engineering，Harbin Institute of Technology；Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province，Henan University；Chongqing Research Institute，Harbin Institute of Technology；National and Local Joint Engineering Laboratory for Synthesis，Transformation and Separation of Extreme Environmental Nutrients；Academician Workstation，Jiangxi University of Chinese Medicine）.Photosensitive pro-drug nanoassemblies harboring a chemotherapeutic dormancy function potentiates cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第2期首页上一页 8 9 10 11 12 下一页尾页共有12页，转到页

期刊文章列表